NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its fourth quarter revenues fell 18 percent compared to Q4 2014.

For the quarter ended Dec. 31, 2015, the molecular diagnostics developer reported revenues fell to $6.6 million from $8.0 million in the year-ago quarter, and missed analysts' estimate for revenues of $7.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.